Fundraising Fox

Lindy Biosciences

Research Triangle Park, US · Founded 2016 · Delaware corporation · 1 known investors

lindybio.com

Lindy Biosciences develops a dehydration technology that produces suspensions of highly concentrated proteins, enabling higher drug dosing in smaller volumes for subcutaneous delivery. The company focuses on drug delivery to reduce the time patients spend administering medication.

BiotechDeep TechMedical Devicesin /lindy-biosciences

Founders & leadership

KL
Karen LeVertExecutive Officer, Director
SG
Sreekar GaddeDirector
DB
Deborah BitterfieldExecutive Officer, Director, Promoter

Investors · 1

Reported raises · per SEC filings

Form D private placements
$1.7MraisedMar 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LeVertDirector
  • Omar FloresExecutive Officer, Director
  • Deborah BitterfieldExecutive Officer, Director, Promoter
  • Joel WhitleyDirector
Offering amount
$2.5M
Amount sold
$1.7M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.3MraisedMar 2022 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LevertDirector
  • Omar FloresDirector
  • Deborah BitterfieldExecutive Officer, Director, Promoter
  • Sreekar GaddeDirector
Offering amount
$5M
Amount sold
$3.3M
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$547.7KraisedJan 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LeVertExecutive Officer, Director
  • Sreekar GaddeDirector
  • Deborah BitterfieldExecutive Officer, Director, Promoter
Offering amount
$1.6M
Amount sold
$547.7K
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$150KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LeVertDirector
  • Deborah BitterfieldExecutive Officer, Director, Promoter
Offering amount
$150K
Amount sold
$150K
First sale
Mar 2018
Incorporated
Limited Liability Company, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.